Agilent Technologies Total Assets 2006-2019 | A

Agilent Technologies total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Agilent Technologies total assets for the quarter ending April 30, 2019 were $8.952B, a 2.92% increase year-over-year.
  • Agilent Technologies total assets for 2018 were $8.541B, a 1.36% increase from 2017.
  • Agilent Technologies total assets for 2017 were $8.426B, a 8.11% increase from 2016.
  • Agilent Technologies total assets for 2016 were $7.794B, a 4.21% increase from 2015.
Agilent Technologies Annual Total Assets
(Millions of US $)
2018 $8,541
2017 $8,426
2016 $7,794
2015 $7,479
2014 $10,815
2013 $10,686
2012 $10,536
2011 $9,057
2010 $9,696
2009 $7,612
2008 $7,007
2007 $7,554
2006 $7,369
2005 $6,751
Agilent Technologies Quarterly Total Assets
(Millions of US $)
Q1 2019 $8,952
Q4 2018 $8,541
Q3 2018 $8,349
Q2 2018 $8,784
Q1 2018 $8,698
Q4 2017 $8,426
Q3 2017 $8,261
Q2 2017 $8,016
Q1 2017 $7,872
Q4 2016 $7,794
Q3 2016 $7,734
Q2 2016 $7,640
Q1 2016 $7,302
Q4 2015 $7,479
Q3 2015 $7,251
Q2 2015 $7,412
Q1 2015 $7,519
Q4 2014 $10,815
Q3 2014 $10,380
Q2 2014 $11,026
Q1 2014 $10,638
Q4 2013 $10,686
Q3 2013 $10,278
Q2 2013 $10,587
Q1 2013 $10,653
Q4 2012 $10,536
Q3 2012 $9,757
Q2 2012 $9,413
Q1 2012 $9,099
Q4 2011 $9,057
Q3 2011 $8,753
Q2 2011 $8,649
Q1 2011 $8,044
Q4 2010 $9,696
Q3 2010 $9,100
Q2 2010 $7,767
Q1 2010 $7,574
Q4 2009 $7,612
Q3 2009 $6,573
Q2 2009 $6,576
Q1 2009 $7,162
Q4 2008 $7,007
Q3 2008 $7,541
Q2 2008 $7,674
Q1 2008 $7,459
Q4 2007 $7,554
Q3 2007 $7,024
Q2 2007 $7,283
Q1 2007 $7,193
Q4 2006 $7,369
Q3 2006 $7,729
Q2 2006 $8,057
Q1 2006 $8,026
Q4 2005 $6,751
Q3 2005 $7,352
Q2 2005 $7,268
Q1 2005 $7,150
Sector Industry Market Cap Revenue
Computer and Technology Electrical Test Equipment $21.944B $4.914B
Agilent Technologies Inc. focuses its expertise on six key markets: Food; Environmental and Forensics; Pharmaceutical; Diagnostics; Chemical and Energy; and Research. Agilent helps ensure that their global food supply is free of contaminants, whether chemical, viral, bacterial or microbiological. The Company's customers include government regulators and labs that control food safety, as well as private companies that produce, package and sell food to the public. Agilent has one of the broadest solutions portfolios of any company serving the pharmaceutical industry. Its solutions provide precise answers for every segment of the pharmaceutical industry, from disease research and drug discovery to drug development, manufacturing and quality control. Agilent gives doctors a head start in the fight against cancer and other diseases. Agilent's immunohistochemistry (IHC) products provide high staining quality, improved standardization and increased efficiency enabling the ultimate goal of increased patient safety.
Stock Name Country Market Cap PE Ratio
Fortive (FTV) United States $26.982B 23.89
AMETEK (AME) United States $19.572B 24.47
Teradyne (TER) United States $7.867B 18.58
Cognex (CGNX) United States $7.549B 36.07
National Instruments (NATI) United States $5.301B 29.34
Itron (ITRI) United States $2.238B 17.66